Loading…

Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates

As an increasingly common cause of skin infections worldwide, the prevalence of antibiotic-resistant ( ) across China has not been well documented. This literature aims to study the resistance profile to commonly used antibiotics, including macrolides, fusidic acid (FA) and mupirocin, and its relati...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget 2017-08, Vol.8 (35), p.58086-58097
Main Authors: Liu, Xingmei, Deng, Shanshan, Huang, Jinwei, Huang, Yaling, Zhang, Yu, Yan, Qin, Wang, Yanhong, Li, Yanyue, Sun, Chengfu, Jia, Xu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-d3ebe298f27e8637980ce893fc507a46682fc95799d43f6623516a4f347737333
cites cdi_FETCH-LOGICAL-c356t-d3ebe298f27e8637980ce893fc507a46682fc95799d43f6623516a4f347737333
container_end_page 58097
container_issue 35
container_start_page 58086
container_title Oncotarget
container_volume 8
creator Liu, Xingmei
Deng, Shanshan
Huang, Jinwei
Huang, Yaling
Zhang, Yu
Yan, Qin
Wang, Yanhong
Li, Yanyue
Sun, Chengfu
Jia, Xu
description As an increasingly common cause of skin infections worldwide, the prevalence of antibiotic-resistant ( ) across China has not been well documented. This literature aims to study the resistance profile to commonly used antibiotics, including macrolides, fusidic acid (FA) and mupirocin, and its relationship to the genetic typing in 34 strains, including 6 methicillin-resistant (MRSA), isolated from a Chinese hospital. The MIC results showed 27 (79.4%), 1 (2.9%) and 6 (17.6%) isolates were resistant to macrolides, FA and mupirocin, respectively. Among 27 macrolide-resistant isolates, 5 (18.5%) were also resistant to mupirocin and 1 (3.7%) to FA. A total of 13 available resistant genes were analyzed in 28 antibiotic-resistant strains using polymerase chain reaction (PCR). The positive rates of macrolide-resistant , , , and low level mupirocin-resistant mutations were 11.1%, 25.9%, 51.9%, 7.4% and 100%, respectively. Other determinants for FA- and high level mupirocin-resistance were not found. The results of multilocus sequence typing (MLST) and pulsed field gel electrophoresis (PFGE) revealed 13 sequence types (STs) and 18 clusters in 23 resistant gene positive isolates. Among these STs, ST5 was most prevalent, accounting for 18.2%. Notably, various clusters were found with similar resistance phenotype and genotype, exhibiting a weak genetic relatedness and high genetic heterogeneities. In conclusion, macrolides, especially erythromycin, are not appropriate to treat skin infections caused by , and more effective measures are required to reduce the dissemination of macrolides, FA and mupirocin resistance of the pathogen.
doi_str_mv 10.18632/oncotarget.19491
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5601635</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1942701259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-d3ebe298f27e8637980ce893fc507a46682fc95799d43f6623516a4f347737333</originalsourceid><addsrcrecordid>eNpVUU9vFyEQJUZjm9oP4MVw9OCvLrDAcjExtf5JmnhoPZMpO_yKYWEF1qTfvtjWWufyJpmZN2_mEfKaDSdsUoK_z8nlBmWP7YSZ0bBn5PAP7riU4vmT_IAc1_pz6CFHPXHzkhzwyYhJCnNI1k-hVlxCghZyotnTBVzJMcxY31G_1TAHR8GFmUKa6bKtoWQXEi1YQ22QHFJYctrTiwbr9U3MLju3VQpbwQ4uhhQcRBpqjtCwviIvPMSKxw94RH58Prs8_bo7__7l2-nH850TUrXdLPAKuZk819iv1WYaHHbV3slBw6jUxL0zUhszj8IrxYVkCkYvRq2FFkIckQ_3vOt2teDsMLUC0a4lLFBubIZg_6-kcG33-beVamBKyE7w9oGg5F8b1maXUB3GCAnzVm3_L9cD49L0Vnbf2j9Xa0H_uIYN9s4s-88se2dWn3nzVN_jxF9rxC0DdpXf</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1942701259</pqid></control><display><type>article</type><title>Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates</title><source>PubMed (Medline)</source><creator>Liu, Xingmei ; Deng, Shanshan ; Huang, Jinwei ; Huang, Yaling ; Zhang, Yu ; Yan, Qin ; Wang, Yanhong ; Li, Yanyue ; Sun, Chengfu ; Jia, Xu</creator><creatorcontrib>Liu, Xingmei ; Deng, Shanshan ; Huang, Jinwei ; Huang, Yaling ; Zhang, Yu ; Yan, Qin ; Wang, Yanhong ; Li, Yanyue ; Sun, Chengfu ; Jia, Xu</creatorcontrib><description>As an increasingly common cause of skin infections worldwide, the prevalence of antibiotic-resistant ( ) across China has not been well documented. This literature aims to study the resistance profile to commonly used antibiotics, including macrolides, fusidic acid (FA) and mupirocin, and its relationship to the genetic typing in 34 strains, including 6 methicillin-resistant (MRSA), isolated from a Chinese hospital. The MIC results showed 27 (79.4%), 1 (2.9%) and 6 (17.6%) isolates were resistant to macrolides, FA and mupirocin, respectively. Among 27 macrolide-resistant isolates, 5 (18.5%) were also resistant to mupirocin and 1 (3.7%) to FA. A total of 13 available resistant genes were analyzed in 28 antibiotic-resistant strains using polymerase chain reaction (PCR). The positive rates of macrolide-resistant , , , and low level mupirocin-resistant mutations were 11.1%, 25.9%, 51.9%, 7.4% and 100%, respectively. Other determinants for FA- and high level mupirocin-resistance were not found. The results of multilocus sequence typing (MLST) and pulsed field gel electrophoresis (PFGE) revealed 13 sequence types (STs) and 18 clusters in 23 resistant gene positive isolates. Among these STs, ST5 was most prevalent, accounting for 18.2%. Notably, various clusters were found with similar resistance phenotype and genotype, exhibiting a weak genetic relatedness and high genetic heterogeneities. In conclusion, macrolides, especially erythromycin, are not appropriate to treat skin infections caused by , and more effective measures are required to reduce the dissemination of macrolides, FA and mupirocin resistance of the pathogen.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.19491</identifier><identifier>PMID: 28938539</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Research Paper</subject><ispartof>Oncotarget, 2017-08, Vol.8 (35), p.58086-58097</ispartof><rights>Copyright: © 2017 Liu et al. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-d3ebe298f27e8637980ce893fc507a46682fc95799d43f6623516a4f347737333</citedby><cites>FETCH-LOGICAL-c356t-d3ebe298f27e8637980ce893fc507a46682fc95799d43f6623516a4f347737333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601635/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601635/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28938539$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Xingmei</creatorcontrib><creatorcontrib>Deng, Shanshan</creatorcontrib><creatorcontrib>Huang, Jinwei</creatorcontrib><creatorcontrib>Huang, Yaling</creatorcontrib><creatorcontrib>Zhang, Yu</creatorcontrib><creatorcontrib>Yan, Qin</creatorcontrib><creatorcontrib>Wang, Yanhong</creatorcontrib><creatorcontrib>Li, Yanyue</creatorcontrib><creatorcontrib>Sun, Chengfu</creatorcontrib><creatorcontrib>Jia, Xu</creatorcontrib><title>Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>As an increasingly common cause of skin infections worldwide, the prevalence of antibiotic-resistant ( ) across China has not been well documented. This literature aims to study the resistance profile to commonly used antibiotics, including macrolides, fusidic acid (FA) and mupirocin, and its relationship to the genetic typing in 34 strains, including 6 methicillin-resistant (MRSA), isolated from a Chinese hospital. The MIC results showed 27 (79.4%), 1 (2.9%) and 6 (17.6%) isolates were resistant to macrolides, FA and mupirocin, respectively. Among 27 macrolide-resistant isolates, 5 (18.5%) were also resistant to mupirocin and 1 (3.7%) to FA. A total of 13 available resistant genes were analyzed in 28 antibiotic-resistant strains using polymerase chain reaction (PCR). The positive rates of macrolide-resistant , , , and low level mupirocin-resistant mutations were 11.1%, 25.9%, 51.9%, 7.4% and 100%, respectively. Other determinants for FA- and high level mupirocin-resistance were not found. The results of multilocus sequence typing (MLST) and pulsed field gel electrophoresis (PFGE) revealed 13 sequence types (STs) and 18 clusters in 23 resistant gene positive isolates. Among these STs, ST5 was most prevalent, accounting for 18.2%. Notably, various clusters were found with similar resistance phenotype and genotype, exhibiting a weak genetic relatedness and high genetic heterogeneities. In conclusion, macrolides, especially erythromycin, are not appropriate to treat skin infections caused by , and more effective measures are required to reduce the dissemination of macrolides, FA and mupirocin resistance of the pathogen.</description><subject>Research Paper</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVUU9vFyEQJUZjm9oP4MVw9OCvLrDAcjExtf5JmnhoPZMpO_yKYWEF1qTfvtjWWufyJpmZN2_mEfKaDSdsUoK_z8nlBmWP7YSZ0bBn5PAP7riU4vmT_IAc1_pz6CFHPXHzkhzwyYhJCnNI1k-hVlxCghZyotnTBVzJMcxY31G_1TAHR8GFmUKa6bKtoWQXEi1YQ22QHFJYctrTiwbr9U3MLju3VQpbwQ4uhhQcRBpqjtCwviIvPMSKxw94RH58Prs8_bo7__7l2-nH850TUrXdLPAKuZk819iv1WYaHHbV3slBw6jUxL0zUhszj8IrxYVkCkYvRq2FFkIckQ_3vOt2teDsMLUC0a4lLFBubIZg_6-kcG33-beVamBKyE7w9oGg5F8b1maXUB3GCAnzVm3_L9cD49L0Vnbf2j9Xa0H_uIYN9s4s-88se2dWn3nzVN_jxF9rxC0DdpXf</recordid><startdate>20170829</startdate><enddate>20170829</enddate><creator>Liu, Xingmei</creator><creator>Deng, Shanshan</creator><creator>Huang, Jinwei</creator><creator>Huang, Yaling</creator><creator>Zhang, Yu</creator><creator>Yan, Qin</creator><creator>Wang, Yanhong</creator><creator>Li, Yanyue</creator><creator>Sun, Chengfu</creator><creator>Jia, Xu</creator><general>Impact Journals LLC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170829</creationdate><title>Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates</title><author>Liu, Xingmei ; Deng, Shanshan ; Huang, Jinwei ; Huang, Yaling ; Zhang, Yu ; Yan, Qin ; Wang, Yanhong ; Li, Yanyue ; Sun, Chengfu ; Jia, Xu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-d3ebe298f27e8637980ce893fc507a46682fc95799d43f6623516a4f347737333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Liu, Xingmei</creatorcontrib><creatorcontrib>Deng, Shanshan</creatorcontrib><creatorcontrib>Huang, Jinwei</creatorcontrib><creatorcontrib>Huang, Yaling</creatorcontrib><creatorcontrib>Zhang, Yu</creatorcontrib><creatorcontrib>Yan, Qin</creatorcontrib><creatorcontrib>Wang, Yanhong</creatorcontrib><creatorcontrib>Li, Yanyue</creatorcontrib><creatorcontrib>Sun, Chengfu</creatorcontrib><creatorcontrib>Jia, Xu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Xingmei</au><au>Deng, Shanshan</au><au>Huang, Jinwei</au><au>Huang, Yaling</au><au>Zhang, Yu</au><au>Yan, Qin</au><au>Wang, Yanhong</au><au>Li, Yanyue</au><au>Sun, Chengfu</au><au>Jia, Xu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2017-08-29</date><risdate>2017</risdate><volume>8</volume><issue>35</issue><spage>58086</spage><epage>58097</epage><pages>58086-58097</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>As an increasingly common cause of skin infections worldwide, the prevalence of antibiotic-resistant ( ) across China has not been well documented. This literature aims to study the resistance profile to commonly used antibiotics, including macrolides, fusidic acid (FA) and mupirocin, and its relationship to the genetic typing in 34 strains, including 6 methicillin-resistant (MRSA), isolated from a Chinese hospital. The MIC results showed 27 (79.4%), 1 (2.9%) and 6 (17.6%) isolates were resistant to macrolides, FA and mupirocin, respectively. Among 27 macrolide-resistant isolates, 5 (18.5%) were also resistant to mupirocin and 1 (3.7%) to FA. A total of 13 available resistant genes were analyzed in 28 antibiotic-resistant strains using polymerase chain reaction (PCR). The positive rates of macrolide-resistant , , , and low level mupirocin-resistant mutations were 11.1%, 25.9%, 51.9%, 7.4% and 100%, respectively. Other determinants for FA- and high level mupirocin-resistance were not found. The results of multilocus sequence typing (MLST) and pulsed field gel electrophoresis (PFGE) revealed 13 sequence types (STs) and 18 clusters in 23 resistant gene positive isolates. Among these STs, ST5 was most prevalent, accounting for 18.2%. Notably, various clusters were found with similar resistance phenotype and genotype, exhibiting a weak genetic relatedness and high genetic heterogeneities. In conclusion, macrolides, especially erythromycin, are not appropriate to treat skin infections caused by , and more effective measures are required to reduce the dissemination of macrolides, FA and mupirocin resistance of the pathogen.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>28938539</pmid><doi>10.18632/oncotarget.19491</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1949-2553
ispartof Oncotarget, 2017-08, Vol.8 (35), p.58086-58097
issn 1949-2553
1949-2553
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5601635
source PubMed (Medline)
subjects Research Paper
title Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A48%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dissemination%20of%20macrolides,%20fusidic%20acid%20and%20mupirocin%20resistance%20among%20Staphylococcus%20aureus%20clinical%20isolates&rft.jtitle=Oncotarget&rft.au=Liu,%20Xingmei&rft.date=2017-08-29&rft.volume=8&rft.issue=35&rft.spage=58086&rft.epage=58097&rft.pages=58086-58097&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.19491&rft_dat=%3Cproquest_pubme%3E1942701259%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-d3ebe298f27e8637980ce893fc507a46682fc95799d43f6623516a4f347737333%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1942701259&rft_id=info:pmid/28938539&rfr_iscdi=true